# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JMP Securities analyst Devin Ryan reiterates Ares Capital (NASDAQ:ARCC) with a Market Outperform and maintains $21 price tar...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said GE HealthCare Technologies Inc. (NASDAQ: GEHC) can go higher.
Ares Capital (NASDAQ:ARCC) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.60 by...
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per shar...
Wells Fargo analyst Timothy O'Shea maintains Ares Capital (NASDAQ:ARCC) with a Equal-Weight and raises the price target ...
B. Riley Securities analyst Bryce Rowe downgrades Ares Capital (NASDAQ:ARCC) from Buy to Neutral and announces $21 price tar...